share_log

UBS Initiates Coverage On Exponent With Neutral Rating, Announces Price Target of $99

Benzinga ·  Jun 1, 2023 05:11

UBS analyst Joshua Chan initiates coverage on Exponent (NASDAQ:EXPO) with a Neutral rating and announces Price Target of $99.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment